Ren T, Shan J, Li M, Qing Y, Qian C, Wang G, . . . Zhou SF. (2015). Small-molecule BH3 mimetic and pan-Bcl-2 inhibitor AT-101 enhances the antitumor efficacy of cisplatin through inhibition of APE1 repair and redox activity in non-small-cell lung cancer. Dove Medical Press.
Chicago Style (17th ed.) CitationRen T, et al. Small-molecule BH3 Mimetic and Pan-Bcl-2 Inhibitor AT-101 Enhances the Antitumor Efficacy of Cisplatin Through Inhibition of APE1 Repair And redox Activity in Non-small-cell Lung Cancer. Dove Medical Press, 2015.
MLA (9th ed.) CitationRen T, et al. Small-molecule BH3 Mimetic and Pan-Bcl-2 Inhibitor AT-101 Enhances the Antitumor Efficacy of Cisplatin Through Inhibition of APE1 Repair And redox Activity in Non-small-cell Lung Cancer. Dove Medical Press, 2015.